Transitioning Neovascular Age Related Macular Degeneration Patients to Aflibercept Following an Initial Treat And Extend Dosing Regimen: 18 Month Results

被引：0
|
作者：
Homer, Natalie [1 ]
Grewal, Dilraj Singh [1 ]
Lyon, Alice T. [1 ]
Mirza, Rukhsana [1 ]
Gill, Manjot [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Ophthalmol, Chicago, IL 60611 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
412 age-related macular degeneration; 552 imaging methods (CT; FA; ICG; MRI; OCT; RTA; SLO ultrasound); 453 choroid: neovascularization;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3975
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Management of Neovascular Age-Related Macular Degeneration Using Bevacizumab With the Treat and Extend Regimen: Clinical Results and Economic Impact
    Shienbaum, G.
    Gupta, O. P.
    Fecarotta, C.
    Regillo, C. D.
    Kaiser, R. S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [42] A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
    Kikushima, Wataru
    Sakurada, Yoichi
    Fukuda, Yoshiko
    Matsubara, Mio
    Kotoda, Yumi
    Sugiyama, Atsushi
    Kashiwagi, Kenji
    PHARMACEUTICALS, 2023, 16 (04)
  • [43] Four-year outcome of aflibercept administration using a treat-and-extend regimen in eyes with recurrent neovascular age-related macular degeneration
    Yuma Tsunekawa
    Keiko Kataoka
    Keiko Asai
    Yasuki Ito
    Hiroko Terasaki
    Japanese Journal of Ophthalmology, 2021, 65 : 69 - 76
  • [44] Four-year outcome of aflibercept administration using a treat-and-extend regimen in eyes with recurrent neovascular age-related macular degeneration
    Tsunekawa, Yuma
    Kataoka, Keiko
    Asai, Keiko
    Ito, Yasuki
    Terasaki, Hiroko
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2021, 65 (01) : 69 - 76
  • [45] A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration Clinical and Economic Impact
    Gupta, Omesh P.
    Shienbaum, Gary
    Patel, Avni H.
    Fecarotta, Christopher
    Kaiser, Richard S.
    Regillo, Carl D.
    OPHTHALMOLOGY, 2010, 117 (11) : 2134 - 2140
  • [46] Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration: A Prospective Clinical Trial
    Decroos, Francis Char
    Reed, David
    Adam, Murtaza K.
    Salz, David
    Gupta, Omesh P.
    Ho, Allen C.
    Regillo, Carl D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 180 : 142 - 150
  • [47] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial
    Hatz, Katja
    Prunte, Christian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192
  • [48] Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-Related Macular Degeneration: A Prospective Clinical Trial
    Calugaru, Dan
    Calugaru, Mihai
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 182 : 204 - 205
  • [49] Intraocular pressure changes during intravitreal aflibercept injection based on treat-and-extend regimen in Japanese patients with neovascular age-related macular degeneration and glaucoma
    Honjo, Junichiro
    Mukai, Ryo
    Itagaki, Kanako
    Tanaka, Keiichiro
    Norikawa, Koki
    Kato, Yutaka
    Kasai, Akihito
    Sugano, Yukinori
    Sekiryu, Tetsuju
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2024, 68 (02) : 91 - 95
  • [50] Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration
    Aki Kato
    Tsutomu Yasukawa
    Iichiro Sugita
    Munenori Yoshida
    Miho Nozaki
    Yoshio Hirano
    Junko Kondo
    Tomohiro Abe
    Kimiko Sugita
    Takahide Okita
    Hiroshi Morita
    Noriaki Takase
    Yuichiro Ogura
    Advances in Therapy, 2022, 39 : 1403 - 1416
12345